Related Experiment Video
Updated: Mar 2, 2026

09:37
Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
Published on: August 15, 2019
10.6K
Recurrent somatic JAK-STAT pathway variants within a RUNX1-mutated pedigree
Kiran Tawana1, Jun Wang2, Péter A Király3
1Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.
European Journal of Human Genetics : EJHG
|May 18, 2017
Summary
Three sisters with a RUNX1 gene variant developed acute myeloid leukemia (AML) due to independent JAK-STAT pathway mutations. This convergent evolution highlights a high-risk AML subtype.
Area of Science:
- Genetics
- Hematology
- Oncology
Background:
- Germline variants in the RUNX1 gene are linked to familial platelet disorders and acute leukemia.
- Somatic events driving leukemic transformation in these families are diverse and poorly understood.
Purpose of the Study:
- To investigate the molecular mechanisms underlying acute myeloid leukemia (AML) development in a family with a germline RUNX1 nonsense variant.
- To define the patterns of leukemia initiation across family members.
Main Methods:
- Whole-exome sequencing of tumor samples from three affected siblings.
- Chromosomal characterization of tumor cells.
- Analysis of germline and somatic variants, including copy number alterations and uniparental disomy.
Main Results:
- All three siblings developed acute myelomonocytic leukemia (AML) at age 5, each harboring the germline RUNX1 variant c.601C>T (p.(Arg201*)).
- Tumor sequencing revealed independent acquisition of variants in the JAK-STAT pathway (JAK2, SH2B3) in all siblings.
- Chromosomal analysis showed copy number gains and uniparental disomy affecting RUNX1, JAK2, and SH2B3, indicating pathway cooperation.
- One sibling with myelodysplasia lacked JAK2/SH2B3 variants, suggesting their specific role in leukemic transformation.
Conclusions:
- This study presents the first example of convergent AML evolution in a RUNX1 pedigree.
- Recurrent acquisition of JAK-STAT pathway variants drives high-risk AML with chemotherapy resistance and relapse.
- Cooperation between RUNX1 and JAK-STAT pathway disruptions is critical for leukemogenesis in this context.
More Related Videos
Related Concept Videos
The JAK-STAT Signaling Pathway
13.4K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
13.4K
The Retinoblastoma Gene
4.8K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.8K
Pleiotropy
43.6K
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
43.6K
Pedigree Analysis
90.2K
Overview
90.2K
X-linked Traits
59.2K
In most mammalian species, females have two X sex chromosomes and males have an X and Y. As a result, mutations on the X chromosome in females may be masked by the presence of a normal allele on the second X. In contrast, a mutation on the X chromosome in males more often causes observable biological defects, as there is no normal X to compensate. Trait variations arising from mutations on the X chromosome are called “X-linked”.
59.2K
Cancers Originate from Somatic Mutations in a Single Cell
15.2K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
15.2K

